Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Is Cel-Sci The Cheapest Company In A Phase III Trial?
Article By:
Peter Epstein
Monday, March 9, 2015 9:48 AM EDT
CEO Geert Kersten of Cel-Sci (CVM) believes his company's valuation is significantly below peers, some of which have drugs at the same or lower Stage. In this interview Mr. Kersten candidly addresses important questions about Cel-SciI.
In this article: CVM
PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing Of Public Offering
Insider Trading Report Edition #185: Notable Insider Buys And Sales
Article By:
Asif Suria
Monday, January 6, 2014 2:38 PM EDT
Notable Insider Buys: Opko Health, BioTime, Wheeler Real Estate Investment Trust, SP Plus Corp., and CEL-SCI.
Notable Insider Sales: Monster Beverage Corp., Fidelity National Financial, FleetCor Technologies, Kodiak Oil & Gas Corp., and Groupon.